Try it
Ophthalmology · Retina: dietary supplements in macular degeneration
Sample itemA 68-year-old non-smoker has intermediate dry age-related macular degeneration in both eyes. Which measure is supported to reduce progression to advanced disease?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. An antioxidant vitamin and zinc formulation
AREDS-type supplements with antioxidant vitamins and zinc reduce progression of intermediate disease. Anti-VEGF is for neovascular disease, and laser or photodynamic therapy are not used for dry disease. Smoking cessation is also advised.
Option by option
A. Monthly intravitreal anti-VEGF injections
Anti-VEGF is used for wet disease and has no role in intermediate dry disease.
B. An antioxidant vitamin and zinc formulation (correct)
Correct. The supplement formulation lowers the risk of progression.
C. Panretinal photocoagulation
Panretinal photocoagulation treats proliferative ischaemia, not drusen.
D. Photodynamic therapy
Photodynamic therapy is for specific neovascular lesions.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…
- GlaucomaWhich drug is given systemically to reduce intraocular pressure in acute angle-closure g…